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Despite remarkable advances in the pharmacologic approach to advanced heart failure, 2WZ to 40% of patients with advanced heart failure will die each year, the majority suddenly and unexpectedly (l-3). Syncope, which is relalively common in patients with heart failure, has many etiologies. In studies of unselected patient groups with syncope, syncape of cardiac a@in is associated with an increased risk of sudden death, whereas syncope of noncardisc origin has a more benign outcome (4-7). In many patients the etiology of synwpe is not determined despite evahmtion, but in the absence of evidence for ventricular tachywdia or other cardiac causes, the risk of sudden death is low (5.7). In patients with advanced heart failure, the relation between the etiology of syncope and sudden death has not been evaluated. The purpose of this study of 491 consecutive patients with advanced heart failure was to -.-assess the incidence of syncope and its importance as a risk factor for sudden death.
Methods
Study group. The study group consisted of 491 consecutive patients with advanced heart failure without a history of cardiac arrest referred to the University of California, Los Angeles Medical Center for optimization of medical therapy, often in conjunction with evaluation for heart hansplantation during the period April 1983 to April 1991. The patients had a mea" age of 50 * 12 years and 391(80%) were male; they had a mean New York Heart Association timctianal class of 3.4 + 0.6 on admission, and a mean let? ventricular ejection fraction of 0.20 * 0.07. Heart failure was due to coronary artery disease in 234 patients (48%). idiooatbic dilated cardiomiopathy in 224 (i6%), v&dar hewtbisease in 25 (5%) and other or undetermined causes in 8 patients (1%). AU patients underwent placement of a pulmonary artery catheter to guide therapy with intravenous followed by oral vasodilators and diuretic drugs tailored to meet hemcdynamic goals (8.9). Only patients with hemodynamic stabiization permitting hospital discharge were included in this study.
At the time of hospitalization all patients were evaluated by the University of California, Los Angeles Arrhythmia Service and were asked in detail about syncope history. Our general approach to patients with heart failure with recent (56 weeks) syncope has included evaluation with history and physical exam&ion, scalar electrocardiogram (ECC Fol!ow-up. Follow-up was considered to start at the time of hospital admission at this institution for optimizatio" of heart failure therapy, "at at the time of syncope. Patients were followed up by one of us in the University of California, Los Angeles Cardiomyopathy Clinic. In the event of death, the circumstances at the time of death were obtained from the family. personal physician and autopsy data when wailable. Telephone co"tact with all patients and their families or physicians. or both, was attempted in May WI. Twenty-four patients (4%) were lost to follow-up witbitt I year (5% of patients with prior syncope vs. 3.9% of those without prior syncope. p = NS).
Results
Cliical chamcteristirs. Of 491 consecutive patients with advanced herat failure without a history ofcardiac arrest, 60 (12%) had had a prior syncopal episode after the onset of heart failure, the majority within the year preceding refen'ai~ consciousness due to seizure was not classified as syncope.
Eleven patients (18%) had had sy"cope within 6 weeks of referral. Table 1 compares the clinical characteristics of patients with and without syncope, Patients in the two groups had a similar degree of heart failure severity, as assessed by serum sodium levels, New York Heart Association functional class at the time of hospital admission and echocardiogmphic and hemodynamic measurements. The cause of heart failure, presence of spontaneous ventricular ectopic beats and use of vasodilator or antiarrhythmic drug therapy did not dBer between oatients with and without sync&.
Patients with syncopewere more likely to have chronic or paroxysmal atria1 fibrillation (33% vs. IS%, p = 0.003), a permanent pacemaker (ES% vs. 6%, p = 0.01)&d a s!ightly but significantly higher pulmonary artery systolic pressure during therapy than that of patients without syn- Mortality and sudden death. After a mean follow-up period of 365 ir 419 days. 165 patients (35%) were alive and well, 148 (30%) had undergone heart transplantation, 69 (14%) had died suddenly, 66 (13%) had died of progressive heart failure, 19 (4%) had died of noncardiac or unknown causes and 24 (4%) were lost to follow-up. For the total group the actuarial rate of mortality from all causes at I year was 29% and the rate of sudden death was 15%. The actuarial l-year rate of mortality from all causes was significantlygreater in patients with than in those without syncope (65% vs. 25%, p < O.tWOl). This increased mortality was predominantly due to the large number of sudden deaths in the patients with syncope. The l-year actuarial risk of sudden death was signiiicantly greater in patients with than in those without syncope (45% vs. 12%, p < 0.00001) {Fig. 1). In patients with syncope, the risk of sudden death did not diier between patients with recent (~6 weeks) or nonrecent (>6 weeks) syncope (p = 0.68). spy. Similarly, syncope was independently related to mortality from all causes (P = 0.005) but not to deaths due to progres& heart failure (p = 0.66). Etiolwy ofayttcope. Table 3 shows the causes of syncope in the study group. Evaluation included electrophysiologic testing in 10 (91%) of II patients presenting within 6 weeks of the syncopal event and in 29 (48%) of all patients with syncope. Of-60 patients, 29 patients (48%) had a cardiac origin of syncope, and 31 patients (52%) had a noncardiac (n = 13) or undetermined (n = 18) origin. Of 29 patients with a cardiac origin of syncope, 21 (72%) had ventricular tachyarrhythmias. including symptomatic nonsustained ventricular tachycardia in 8, sustained ventricular tachycardia recorded during syncope in 5, drug-induced torsade de pointes in 2 and inducible sustained monomorphic ventricular tachycardia in 6. Five patients bad syncope due to bmdyarrhythmia, including high degree heart block in four and sinus bradycardia due to a beta-adrenergic blocking drug in one. Syncope was due to suprwentricular tachycardia in one patient and to critical valvtdar stenosis in two patients.
Of 31 patients without a cardiac cause of syncope. 9 had orthostatic hypotension, 3 had situational syncope and 1 patient had neurologic syncope due to a tmsient ischemic attack. The cause of syncope was undetermined in 18 patients despite evaluation, including electrophysiologic testing in 10 patients (56%). Table 4 compares the clinical characteristics of patients with cardiac syncope and those with syncope from other causes. The two patient groups had a similar severity of heart failure as measured by serum sodium, New York Heart Association functional class, left ventricular ejection frwtion and hemodynamic measurements. The time from SYD cop to referral, cause of heart failure, presence of atrial fibrillation, use of vasodilator therapy and p+rma"ent pacemakers did not differ between groups. Patients with cardiac syncope were signilicantly older than patients with other causes of svnco~e (54 f 11 vs. 45 + 13 wars, c = 0.W') and bad a lo& ;&onary artery syst&c pressure during vasodilator therapy (40 + 10 vs. 47 + IS mm Hg, p = 0.04). By logistic regression analysis, coronary artery disease C$ = O.%), time from syncope to referral (p = 0.60) and serum sodium (p = 0.82) were not predictive of L cardiac origin of syncope.
Sudden death and &logy of snmpe. Nine (31%) of 29 patients with cardiac syncope and 7 (23%) of 31 patients with syncape from other causes died suddenly. The actuarial risk of sudden death by I year did not diJTer between patients with cardiac syncope and patients r*ith syncop from other causes (4% vs. 39%. p = NS) (Fig. 2) . In the 29 patients who underwent electrophysiologic testing, the I-year actuarial risk of sudden death did not diier statistically between oatients with cardiac syncwe and those with other causes of syncope (54% vs. 32%. p = NS). Similarly, the risk of sudden death did not d&r between patients who did or did not undergo electrophysiologic t&g (47% vs. 51%. p = NS). Mortality from all causes did not dim between pa- dents with cardiac syncopeand patients with other causw of syncope (62% vs. 66%, p = NS). Figure 3 reiates :he etiology of syncope and type of therapy to sudden death. of21 patients with cardiac syncape due to ventricular tachyarrhythmias, 8 received electrophyoiologicelly guided antiarrhythmic therapy that rendered venttiutlar tachvcardia noninducible or well tolerated in 7 and poorly to&&d in 1 patient. Nine patients received empiric anliarrhythmic therapy to suppress ambient ectopic activity (class I agents in six, amiodarone in three). The incidence of sudden death did not diier between patients receiving therapy guided by electmphysiologic testing (one sudden death in eight patients) and those receiving therapy administered empirically (four sudden deaths in nine patients, Pit 3. origin of syncap. type of therapy and incidence of sudden death during follow-up in M patients with advanced heart failure and ryncope. B = beta: CHP = congestive heart failure; EPS = elcctrophysiologic study; SD = sudden death; SVT = suprauentricnlar tachycardia. Wther includes withdrawal of a&c rhythmic drugs in two patients with drug-induced torsade de primes, implanlatiorl of a cardiovelter-defibrillator in one patient and coronary artery bypass graft surgery in one patient. See text for discussion. p = 0.36). although the number of patients in each group was small.
Five patients had cardiac syncope due to bradyanhythmias. Four of the live underwent permanent pacemaker implantation, one of whom subsequently died suddenly. In the fifth patient, therapy with a beta-adrenergic blocking drug was withdrawn, resultit@ in resolution of symptoms.
Of31 patients without a cardiac cause of syncope, 4 were treated with class I drugs, 7 received amiodarone for atrial arrhythmias or frequent venlticular ectopic activity and 20 did not receive an antiarrhythmic drug. Four patients (21%) receiving no : ntiarhytbmic agents and three patients (27%) receiving antrarrhythmic drugs died suddenly.
Discussion
Syncope of cardiac versus noncardlac causes. Syncope, whether ofcardiac or noncardiac origin, indicates a transient loss of central nervotts system petlitsion. In large studies of patients with syncope, a cardiac cause of syncope is associated with increased risk of sudden death, presumably because the previously transient abnormality becomes persistear with fatal consequences. For example, nonsustained ventricular tachycardia becomes sustained and degenerates into ventricular fibrillation. I;t these studies of unselected patients. noncardiac and undetermined caues of syncope have a benign prognosis without long-term consequences (4-7.13). In striking contrast lo patients without heart fallwe, patients with advanced heart failure who have syncope of noncardiac or undetermined origin have a markedly increased risk for sudden death. Several posstMe explanations for this discretwtcv exist. patients with heart failure classified as having syncope of noncardiac or undetermined origin may be more likely than patients without heart faihue to have a cardiac origin of syncope that has escaped diagnosis. Electmcardio~aphic ~mon&ing and pmgrammed electrical stimulation are frequently used to determine the etiology of syncope but may-be less predictive in patients with advanced heart failure. During ECG monitoring, asymptomatic complex ectopic activity was recorded in 82% of our patients. However, the majority of patients with class III and IV heart failure have complex ventricular ectopic activity during ambulatory monitoring (14-19). Such activity has been associated with an increased risk of sudden death in many, but no1 all, studies of patients with advanced heart failure (15-19). Yet, unless presyncope or syncope occurs during recordings associated with ventricular ectopic activity, it is difficult to attribute syncope to this highly prevalent arrhythmia. Only 13% of our patients with syncope had nonsustained ventricular tachycardia with symptoms implicating this arrhythmia as the cause of syncope.
In our patients, ventricular tachycardia was initiated with programmed stimulation in only 27% of patients with syncope tested, a finding consistent with prior studies (12) of electmphysiologic testing in patients with syncape who have _ _ SD SD 9D SD SlNCt"tat heaPt mea%. mt the pr&cttve val"e 01 nontnducibilily of arrhythmia at programmed electrical stimulation in high risk patients with a severely depressed left ventricular ejection fraction has been questioned (20-23).
Programmed stimulation, useful for detecting ventricular tachycardia due to reentry within an infarct scar, may be less useful in detecting arrhythmias associated with hypertrophy and noninfarct-related causes. Ventricular tachycardia due to early afterdepolarizations with triggered activity or ahnormal automaticity, modulated by electrolyte abnormalities and changes in autonomic tone, may not be inducible with programmed stimulation (24). In studies of patients with heart failure and idiopathic dilated cardiomyopathy who have not previously had spontaneous sustained ventricular tachycardia, sustained monomorphic ventricular tachywdia is inducib!e in only 0% to 13% of patients (21-23). However, the risk of sodden death is high despite the absence of inducible venhicular tachycardia.
perhaps because of bradyarrhythmias or nonreentrant mechanisms of ventricular tachycardia (25).
be diagnosed. but flu&r&g ahnomnlities iotloenced by humoral or autonomic trieeers tow eo undetected (26.28). In Similarly, detection of sporadic bradyarrhythmias by ambulatory ECG recording or P.ogrammed stimulation is limited (X,27). Severe, persistent abnamnlities can usxdly activity at the peroneal nerve during induced ventricular tachycardia and ventricular pacing in 16 patients, the majority with prior syncope. Hemodynamic stabiity during ventricular tachycardia was directly related to the increase in sympathetic nerve activity independent of tachycardia rare and left ventricular ejection fraction (351. Abnormally depressed heart rate variability. another measure of autonomic dysfunction, has been reported in patients with bean failure and may be related to sudden death (36,37). Sywopz from minor hemodynamic stresses, such as standing or mictsrition. may identify patients with heat failure who have inadequate sympathetic nerve responses or paradoxic cardiopulmonary or arterial bxoreceptor refkxes that under certain circumstances tend to lead to hypoteosion with a nalignant outcome. It is not known whether evaluation of reflex responses mediated by the autonomic nervous system-perhaps by using tilt testiog, sympathetic nerve Rsponse to ventricular pacing and assessment of heart rate variability-will allow betteridentilication of the highest risk patients.
therapy was somelimes instituted before our evaluation. .Althounh electroohvsioltic test& was not wrformed in all
Lttitations of the My. 'I?+ is B retrospective study. Patients had syncope at various times preceding referral, and our study group, no p&&t had aTb~dyarrhythmi~ cause of patients. it was '&for&d in 91% of tl& patients with syncope established at electmphysiologic test&. In sumrecent syncope. In a recent analysis of electmphysiologic may, the diagnosis of syncope of noncardiac or ondetertesting in patients with syncape, including a subset with mined origin reflects the limits of available diagnostic tests in markedly decreased left ventricular function. the risk of advanced heart failure and is not indicative of a more sudden death was similarly high in patients with diagnostic favorable outcome.
A&rh~hmic d& therapy may hove limited efficacy in preventing sudden death in patients with severely depressed vennicolar function (29-31). In fact, in survivors of myocare In patients with heart failure who have an identified dial infarction sod in patients with heart failure, therapy with cardiac cause of syocope, the risk of sudden death remains class I drugs may a&ally increase the risk of sudden death (32.33). In our study patients. there was no sign&cant high despite therapy directed to the cane of the syttcope. diiereoce io the risk of sudden death between patients receiving aotiarrhythmic therapy guided by programmed stimulation and those treated empirically. although the number of patients is relatively smali.
P&bk role of autono& nervous system. Another ponumbers of patients; therefore, conclusions regarding the and nondiagnostic eleetmphys~ologi~ tests (38). Our evalmProgoostic sigoiicaoce of a particular subgroup. for example those with torsadc de paiotes, cannot be made. Only one tion of syncope did wt include test&g of autonomic nervous patient with syncope received an implantable defibrillator. Our patients have advanced heart failure wrtaoting referral system activity or cardiopolmonary sod arterial bamrecep for evaluation for heart transdantation, representing the most severe end of the spectrum of ootpati&ts with heart tar reflexes. Some etiologies of syneope included only small failure. Therefore. our ~solts may oat be aDPtiCable to all patients with hei failure.
_ __ Cmdusiom. Patients with advanced heart failure rho have sync+ are at especially high risk for sudden death regardless of the etiology of syncope. Although evaluation and therapy directed toward the uoderlyiogcause of syncope is recommended. the caose often remains undetermined and the rate of sudden death is higb eveo with therapy. Transient abnormalities io autonoodc activity or paradoxic barorecepteotial reason for the adverse prognostic significance of syncape is that it may identity a person with impaired physiologic compensatory reflexes, who is unable to maintain blood pressure in the face of chalIeoges to homeostasis. sttch as ortbostasis or mild arrhvthmias. Thus, a simple faint may become sustabxd, leading to potentially lethal con%-tar reflex responses wntriiuting to syncope could acccum qoences, such BS ischemia or arrhythmias. Fergoson and for the low diagnostic yield of standard testing. Perhaps associates (34) stodied cardiopulmotwy barnreceptors in evaluation of autooomif nervous system responses may hean failure and reported paradoxic forearm vasodilation in improve detection of the cause of syncope and aid in resoonse to lower bodv neaative oressore in some patients.
prognostication. Further study is needed to determine In ; study of the sym&l& n&e response to ve~tiicular whether an aggressive approach to diagnosis and themPY tachyeardia, Smith et al. (35) recorded sympathetic nerve can reduce the incidence of sudden death in these patients.
Earlier consideration for heart transplantation may be warranted in patients with heart failure who have a history of syncape.
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